Sens. Elizabeth Warren, D-Mass., Cory Booker, D-N.J., and Ron Wyden, D-Ore., today urged the Food and Drug Administration to review how accurately pulse oximeters monitor blood oxygen levels, citing multiple studies suggesting they provide misleading measures to patients of color.

"In order to reduce health disparities and restore trust among communities of color, we must reevaluate the ways in which current practices and clinical tools themselves potentially worsen outcomes for people of color," the senators wrote. "With an ongoing pandemic disproportionately affecting communities of color, it can be a matter of life or death that the very device that could help these communities and their health care providers detect the need for urgent care is less likely to alert them to risks simply because of the color of their skin.”

Related News Articles

Headline
A National Institutes of Health study published April 2 found that blood pressure patterns observed during the first half of pregnancy can determine a woman's…
Headline
A study published March 31 by the National Institutes of Health found that adults living in rural areas have worse cardiovascular health than those in urban…
Headline
The AHA yesterday released its 2025 Advocacy Agenda that details the association's key priorities for Congress, the Administration, regulatory agencies and…
Headline
In this conversation, three experts from Boston Medical Center discuss the development of its Health Equity Accelerator, the partnerships needed to sustain the…
Headline
In this conversation, Terry Scoggin, CEO of Titus Regional Medical Center, discusses how the organization designed a system of care to ensure that every…
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…